A8542-50mg | Triflurdine (Viroptic) [70-00-8] Clinisciences

Background

Trifluridine (also called trifluorothymidine or TFT) is an anti-herpesvirus antiviral drug, used primarily on the eye. It was sold under the trade name, Viroptic, by Glaxo Wellcome, now merged into GlaxoSmithKline. The brand is now owned by Monarch Pharmaceuticals, which is wholly owned by King Pharmaceuticals.

Chemical Properties

Physical Appearance	A solid
Storage	Store at -20°C
M.Wt	296.2
Cas No.	70-00-8
Formula	C₁₀H₁₁F₃N₂O₅
Solubility	≥14.45 mg/mL in DMSO; ≥17.03 mg/mL in EtOH with ultrasonic; ≥3.72 mg/mL in H2O with ultrasonic
Chemical Name	1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione
SDF	Download SDF
Canonical SMILES	C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O
Shipping Condition	Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips	We do not recommend long-term storage for the solution, please use it up soon.

Quality Control

Purity = 98.55%

COA (Certificate Of Analysis)
HPLC
NMR (Nuclear Magnetic Resonance)
MSDS (Material Safety Data Sheet)
Datasheet

Triflurdine (Viroptic) [70-00-8]

Katalog-Nummer A8542-50mg

Contact local distributor :

Marke : APExBIO Technology

Contact local distributor :

Background

Chemical Properties

Quality Control

Sie könnten auch an folgenden Produkten interessiert sein: